Pharmacogenomics aims to develop rational means to optimize drug therapy with respect to the patient’s genotype, ensuring maximum drug efficiency with minimal adverse effects. A deeper understanding of different groups and populations improves pharmacovigilance, clinical trials, and the real-world therapeutic efficiency of drugs.
Explore related content and topics
White Paper
Transparency and Reliability
Adjudication can be a tool to improve the confidence of trial data, although it is essential to have a clear and defined process. Historically,…
White Paper
Sponsor and CRO Pharmacovigilance Alliances
Outsourcing pharmacovigilance activities is a standard business practice in a continuously expanding market segment. In the past, outsourced safety…
White Paper
Pharmacovigilance Oversight: Outsourcing QPPV Services
This white paper provides insight into considerations when outsourcing Qualified Person for Pharmacovigilance (QPPV) services. It also touches upon…